Journal
MOLECULAR NEUROBIOLOGY
Volume 55, Issue 12, Pages 9156-9168Publisher
SPRINGER
DOI: 10.1007/s12035-018-1063-3
Keywords
Stroke; Recombinant tissue plasminogen activator; Reperfusion; Vasculoprotection
Categories
Ask authors/readers for more resources
Benefits from thrombolysis with recombinant tissue plasminogen activator (rt-PA) after ischemic stroke remain limited due to a narrow therapeutic window, low reperfusion rates, and increased risk of hemorrhagic transformations (HT). Experimental data showed that rt-PA enhances the post-ischemic activation of poly(ADP-ribose)polymerase (PARP) which in turn contributes to blood-brain barrier injury. The aim of the present study was to evaluate whether PJ34, a potent PARP inhibitor, improves poor reperfusion induced by delayed rt-PA administration, exerts vasculoprotective effects, and finally increases the therapeutic window of rt-PA. Stroke was induced by thrombin injection (0.75UI in 1l) in the left middle cerebral artery (MCA) of male Swiss mice. Administration of rt-PA (0.9mgkg(-1)) or saline was delayed for 4h after ischemia onset. Saline or PJ34 (3mgkg(-1)) was given intraperitoneally twice, just after thrombin injection and 3h later, or once, 3h after ischemia onset. Reperfusion was evaluated by laser Doppler, vascular inflammation by immunohistochemistry of vascular cell adhesion molecule-1 (VCAM-1) expression, and vasospasm by morphometric measurement of the MCA. Edema, cortical lesion, and sensorimotor deficit were evaluated. Treatment with PJ34 improved rt-PA-induced reperfusion and promoted vascular protection including reduction in vascular inflammation (decrease in VCAM-1 expression), HT, and MCA vasospasm. Additionally, the combined treatment significantly reduced brain edema, cortical lesion, and sensorimotor deficit. In conclusion, the combination of the PARP inhibitor PJ34 with rt-PA after cerebral ischemia may be of particular interest in order to improve thrombolysis with an extended therapeutic window.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available